BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Pancreatic cancer AND PRKACA, MGC48865, 5566, ENSG00000072062, P17612, PKACA, MGC102831
9 results:

  • 1. Gene Rearrangement and Expression of prkaca and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms.
    Itoh T; Omori Y; Seino M; Hirose K; Date F; Ono Y; Mizukami Y; Aoki S; Ishida M; Mizuma M; Morikawa T; Higuchi R; Honda G; Okamura Y; Kinoshita K; Unno M; Furukawa T
    Mod Pathol; 2024 Jan; 37(1):100358. PubMed ID: 37871652
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Investigation of -prkaca/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.
    Maimaitiaili Y; Fukumura Y; Hirabayashi K; Kinowaki Y; Naito Y; Saito A; Rong L; Nakahodo J; Yao T
    Virchows Arch; 2022 Dec; 481(6):865-876. PubMed ID: 36152045
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Protein modifications throughout the lung cancer proteome unravel the cancer-specific regulation of glycolysis.
    Duan Y; Li J; Wang F; Wei J; Yang Z; Sun M; Liu J; Wen M; Huang W; Chen Z; Lu Z; Yang JH; Wei G
    Cell Rep; 2021 Dec; 37(12):110137. PubMed ID: 34936872
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype.
    Mattiolo P; Hong SM; Paolino G; Rusev BC; Marchegiani G; Salvia R; Andrianello S; Capelli P; Piccoli P; Parolini C; Scarpa A; Lawlor RT; Luchini C
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32806726
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [The therapeutic strategy after noncurative endoscopic submucosal dissection for early gastric cancer].
    Zhou H; Guo CG; Chen YT; Dou LZ; Zhang YM; Wang GQ; Zhao DB
    Zhonghua Zhong Liu Za Zhi; 2019 Nov; 41(11):865-869. PubMed ID: 31770856
    [No Abstract]    [Full Text] [Related]  

  • 6. Recurrent Rearrangements in prkaca and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.
    Singhi AD; Wood LD; Parks E; Torbenson MS; Felsenstein M; Hruban RH; Nikiforova MN; Wald AI; Kaya C; Nikiforov YE; Favazza L; He J; McGrath K; Fasanella KE; Brand RE; Lennon AM; Furlan A; Dasyam AK; Zureikat AH; Zeh HJ; Lee K; Bartlett DL; Slivka A
    Gastroenterology; 2020 Feb; 158(3):573-582.e2. PubMed ID: 31678302
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. DNAJB1-prkaca fusions occur in oncocytic pancreatic and biliary neoplasms and are not specific for fibrolamellar hepatocellular carcinoma.
    Vyas M; Hechtman JF; Zhang Y; Benayed R; Yavas A; Askan G; Shia J; Klimstra DS; Basturk O
    Mod Pathol; 2020 Apr; 33(4):648-656. PubMed ID: 31676785
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Fibrolamellar Hepatocellular Carcinoma with Multiple Lung Metastases Treated with Multidisciplinary Therapy.
    Tanaka H; Hijioka S; Iwaya H; Mizuno N; Kuwahara T; Okuno N; Ito A; Kuraoka N; Matsumoto S; Obata M; Kurita Y; Yasuda M; Shimizu Y; Kuroda H; Sato Y; Haneda M; Sasaki E; Yatabe Y; Hara K
    Intern Med; 2018 Dec; 57(24):3537-3543. PubMed ID: 30101933
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genomic spectra of biliary tract cancer.
    Nakamura H; Arai Y; Totoki Y; Shirota T; Elzawahry A; Kato M; Hama N; Hosoda F; Urushidate T; Ohashi S; Hiraoka N; Ojima H; Shimada K; Okusaka T; Kosuge T; Miyagawa S; Shibata T
    Nat Genet; 2015 Sep; 47(9):1003-10. PubMed ID: 26258846
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.